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Abstract
Background: Septic shock can be defined both by the presence of hyperlactatemia and need of vasopressors.
Lactate levels should be measured after volume resuscitation (as per the Sepsis-3 definition). However, currently, no
studies have evaluated patients who have been excluded by the new criteria for septic shock. The aim of this study
was to determine the clinical characteristics and prognosis of these patients, based on their lactate levels after initial
fluid resuscitation.
Methods: This observational study was performed using a prospective, multi-center registry of septic shock, with the
participation of 10 hospitals in the Korean Shock Society, between October 2015 and February 2017. We compared the
28-day mortality between patients who were excluded from the new definition (defined as lactate level <2 mmol/L
after volume resuscitation) and those who were not (≥2 mmol/L after volume resuscitation), from among a cohort of
patients with refractory hypotension, and requiring the use of vasopressors. Other outcome variables such as
in-hospital mortality, intensive care unit (ICU) stay (days), Sequential Organ Failure Assessment (SOFA) scores
and Acute Physiology and Chronic Health Evaluation (APACHE) II scores were also analyzed.
Results: Of 567 patients with refractory hypotension, requiring the use of vasopressors, 435 had elevated
lactate levels, while 83 did not have elevated lactate levels (either initially or after volume resuscitation), and
49 (8.2%) had elevated lactate levels initially, which normalized after fluid resuscitation. Thus, these 49 patients
were excluded by the new definition of septic shock. These patients, in whom perfusion was restored, demonstrated
significantly lower age, platelet count, and initial and subsequent lactate levels (all p < 0.01). Similarly, significantly lower
28-day mortality was observed in these patients than in those who had not been excluded (8.2% vs 25.5%,
p = 0.02). In-hospital mortality and the maximum SOFA score were also significantly lower in the excluded
patients group (p = 0.03, both).
Conclusions: It seems reasonable for septic shock to be defined by the lactate levels after volume resuscitation.
However, owing to the small number of patients in whom lactate levels were improved, further study is warranted.
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Background
Sepsis and septic shock are serious public health prob-
lems, and have accounted for more than USD 20 billion
of all hospital costs in the USA in 2011 [1]. The inci-
dence of sepsis continues to increase owing to the grow-
ing population of aging adults with chronic diseases, and
is associated with higher mortality rates despite advances
made in the understanding and management of it [2–4].
Recently, the Society for Critical Care Medicine and
European Society of Intensive Care Medicine put to-
gether a taskforce, with the aim of developing a new def-
inition for sepsis and septic shock (Sepsis-3). Based on
this, septic shock was defined as a subset of sepsis that
includes underlying circulatory cellular and metabolic
abnormalities. Based on Sepsis-3, septic shock was clin-
ically defined as sepsis associated with persisting
hypotension, requiring the use of vasopressors to main-
tain mean arterial pressure (MAP) ≥65 mmHg, and
serum lactate >2 mmol/L (18 mg/dL), despite adequate
volume resuscitation [5]. It is important for clinicians to
realize that the definition of septic shock should be
based on the lactate levels after volume resuscitation, as
per the Sepsis-3 definition, and not on the lactate levels
at the time of the recognition of septic shock. Although
there is currently no literature based on controlled data
to support the definition of septic shock based on initial
fluid resuscitation, it may be possible to follow the exist-
ing definition as the average pre-randomization volumes
of fluid, used in recent interventional studies, such as
the ProCESS, ProMISE, and ARISE trials, were approxi-
mately 30 mL/kg or 2 L [6–8]. No studies to date have
evaluated the prognoses of patients with initial lactate
elevation >2 mmol/L, which then reduces to < 2 mmol/
L, after fluid resuscitation – these are the patients who
are excluded from the definition of septic shock, based
on the Sepsis-3 definition.
To address this issue, we aimed to determine the clin-
ical characteristics and prognosis of those patients who
were excluded from the definition of septic shock based
on their lactate levels after initial fluid resuscitation. For
this, we used data from a prospective, multi-center regis-
try of patients with septic shock, as part of which serum
lactate levels are routinely measured at the time of the
recognition of the shock and after the fluid challenge
Methods
Study design and population
This prospective, multi-center, observational study was
conducted in 10 Korean university affiliated hospital
emergency departments (ED) using data from the
Korean Shock Society (KoSS) septic shock registry, from
October 2015 to February 2017. The KoSS is a collab-
orative research network that is involved in investigating
and improving the quality of diagnosis and management
of sepsis, and was established in 2013. Since October
2015, investigators who are part of the KoSS have been
prospectively collecting data pertaining to patients with
septic shock at 10 teaching hospitals across South Korea
(Additional file 1) [9]. In this septic shock registry, pa-
tients who were aged ≥ 19 years and met the inclusion
criteria were enrolled. The inclusion criteria included
evidence of refractory hypotension or hypoperfusion in
patients with suspected or confirmed infection [6–8].
Hypotension was defined as a systolic blood pressure
(SBP) <90 mmHg, MAP <70 mmHg, or SBP decrease
>40 mmHg [10]. Refractory hypotension was defined as
persistent hypotension despite the administration of fluid
challenge (20–30 mL/kg) or of crystalloid solution, was
administered over 30 minutes. At least 1 L of crystalloid
solution was administered to patients with extremely low
body weight or as the requirement of vasopressors to
maintain SBP ≥90 mmHg or MAP ≥70 mmHg. Serum lac-
tate levels were routinely measured at the time of the rec-
ognition of shock and after the delivery of fluid challenge.
Hypoperfusion was defined as serum lactate levels ≥4
mmol/L. Patients were excluded from the study if they
were in a “Do Not Attempt Resuscitation” state; if they
met inclusion criteria 6 hours after arrival in the ED; if
they were transferred from other hospitals and did not
meet the inclusion criteria on ED arrival; or if they were
transferred directly from the ED to other hospitals. The
ED septic shock protocol in our country employs the
6-hour septic shock bundle; hence, we excluded patients
that met the inclusion criteria 6 hours after arrival in the
ED, so as to minimize the effect of different treatments in
each hospital. The institutional review board of each insti-
tution approved the study protocol and informed consent
was obtained before data collection (Additional file 2).
In this study, patients (enrolled in the septic shock
registry) who did not receive vasopressors regardless of
lactate levels or those in whom the subsequent lactate
levels were not measured were excluded. This popula-
tion with refractory hypotension, requiring vasopressors,
was divided into two groups according to the initial lac-
tate levels (Fig. 1). Each of these groups was further di-
vided based on the subsequent lactate levels after fluid
resuscitation. Finally, 28-day mortality in patients in
whom the initial lactate levels were > 2 mmol/L and then
reduced to < 2 mmol/L after fluid resuscitation, who did
not meet the new criteria for septic shock, was com-
pared to that in patients in whom the lactate levels
remained > 2 mmol/L.
Data collection
The case report form of the KoSS septic shock registry,
includes standard definitions of 200 variables including
clinical characteristics, therapeutic interventions, and out-
come of patients with septic shock, and an investigator
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manual was developed based on a literature review and a
consensus of the study investigators. The data are col-
lected via a standardized registry form and entered into a
web-based electronic database. Outliers or incorrect
values are primarily filtered by this data entry system. In
addition, the principal investigator of every site works with
a designated local research coordinator, who is responsible
for ensuring the accuracy of the data entry and verifying
the records. A quality management committee, which
consists of emergency physicians, local research coordina-
tors, and investigators from every ED, was established to
monitor and review data quality regularly. Members from
the committee provide feedback on the results of the qual-
ity management process to the research coordinators and
investigators, and doubts pertaining to the data are clari-
fied either through the use of the system’s query function
or directly through a telephone call.
For our study, demographic and clinical data, includ-
ing age, gender, medical history, initial vital signs, sever-
ity, laboratory values on admission, and interventions
were retrieved from the septic shock registry. The pri-
mary endpoint of this study was 28-day mortality. The
secondary outcomes were in-hospital mortality, ED dis-
position, and the length of stay in the ICU and in hos-
pital. Severity of septic shock was assessed using the
disease severity score. The sequential organ failure as-
sessment (SOFA) score and the maximum SOFA and
Acute Physiology and Chronic Health evaluation (APA-
CHE) II scores were evaluated using the worst parame-
ters, within 24 hours after ED arrival [11, 12].
Statistical analyses
Continuous variables analyzed as the mean ± standard
deviation or median with the interquartile range, and ab-
solute or relative frequencies were analyzed for the cat-
egorical variables. The Student t test or Mann-Whitney
U test were used to compare the continuous variables,
and the chi-square test or the Fisher exact test was used
for categorical variables. Comparisons of 28-day mortal-
ity and other outcomes in the two groups, based on the
recovery of perfusion (lactate level), were performed.
A two-sided P value ≤0.05 was considered statistically
significant. All statistical analyses were performed
using SPSS for Windows version 18.0 (SPSS Inc.,
Chicago, IL, USA).
Results
Clinical characteristics
During the study period, 1046 patients were enrolled in
the KoSS septic shock registry. Of these, 292 patients
who had hyperlactatemia without refractory hypotension
were excluded. There were also 187 patients, in whom
the subsequent lactate levels after volume resuscitation
were not measured, who were also excluded (Fig. 1). Fi-
nally, 567 patients were included in our study. Of these,
435 patients had elevated lactate levels (≥2 mmol/L)
after fluid resuscitation. There were 83 patients in whom
the lactate level was not elevated either initially or after
fluid resuscitation. In 49 patients, elevated lactate levels
were observed initially but these decreased after fluid re-
suscitation. The baseline characteristics of 484 patients,
based on the Sepsis-3 definition, are outlined in Table 1.
The median age of the cohort was 71 years and 57.6% of
these patients were male. There was no significant differ-
ence in comorbidities between the patients with sepsis
in whom perfusion was restored and patients with septic
shock as per the Sepsis-3 definition. There was no sig-
nificant difference between the two groups in the focus
of the infection. The rate of positive cultures and the fre-
quency of resistance to initial antibiotics were not sig-
nificantly different between the groups.
The median initial and subsequent lactate levels dif-
fered significantly, and the platelet count and prothrom-
bin time were also significantly different between the
two groups (Table 2). The arterial pH, and the bicarbon-
ate and procalcitonin levels were significantly different
Fig. 1 Patient flow diagram. f/u follow up
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(p < 0.01, p < 0.01, and p = 0.02, respectively), but the
other laboratory findings did not significantly differ
between the two groups.
Outcome variables
We compared the clinical outcomes of the group of
patients who were excluded from the new septic shock
definition (the excluded group, defined by initial lactate
level ≥2 mmol/L; subsequent lactate level <2 mmol/L)
with the Sepsis-3 septic shock group (defined by
subsequent lactate level ≥2 mmol/L regardless of initial
lactate level). The 28-day mortality was significantly
lower in the excluded group than in the Sepsis-3 septic
shock group (8.2% vs 26.4%, p = 0.01) (Table 3). The ex-
cluded group also had lower in-hospital mortality than
in the Sepsis-3-defined septic shock group (12.2% vs
30.1%, p = 0.03). The maximum SOFA scores in the ex-
cluded group within 24 hours after ED arrival were
significantly lower than in the Sepsis-3 septic shock
group (p = 0.03). The in-hospital mortality, SOFA score,
APACHE II score, and length of ICU stay and hospital
stay were not significantly different between the two
groups.
Comparison of outcomes according to lactate level,
hypotension, and vasopressor requirement
The cohort was divided according to the lactate level,
hypotension, and vasopressor requirement. The 28-day
mortality in group 1 (patients who were hypotensive
after fluids and vasopressor therapy and serum lactate
levels >2 mmol/L) was 25.5%. The outcomes of the other
groups are summarized in Table 4.
Table 1 Baseline characteristics of the study population according to the definition of Sepsis-3
Variables Overall (N = 484) Sepsis with restored perfusion (n = 49) Sepsis-3 septic shock (n = 435) p
Age (years) 71 (60–78) 74 (69–79) 70 (60–78) 0.05
Sex (male) 279 (57.6) 29 (59.2) 250 (57.5) 0.88
Comorbidities
Hypertension 218 (45.0) 28 (57.1) 190 (43.7) 0.10
Diabetes mellitus 169 (34.9) 14 (28.6) 155 (35.6) 0.35
Cardiac disease 64 (13.2) 6 (12.2) 58 (13.3) 1.00
Cerebrovascular disease 72 (14.9) 10 (20.4) 62 (14.3) 0.29
Chronic lung disease 29 (6.0) 5 (10.2) 24 (5.5) 0.20
Hematologic malignancy 27 (5.6) 3 (6.1) 24 (5.5) 0.75
Metastatic cancer 101 (20.9) 9 (18.4) 92 (21.1) 0.72
Chronic renal disease 42 (8.7) 4 (8.2) 38 (8.7) 1.00
Liver cirrhosis 78 (16.1) 5 (10.2) 73 (16.8) 0.31
Suspected infection focus
Respiratory infection 153 (31.6) 21 (42.9) 132 (30.3) 0.08
Gastrointestinal 82 (16.9) 6 (12.2) 76 (17.5) 0.43
Hepatobiliary pancreas 113 (23.3) 8 (16.3) 105 (24.1) 0.29
Bone and soft tissue 24 (5.0) 4 (8.2) 20 (4.6) 0.29
Others 14 (2.9) 0 (0.0) 14 (3.2) 0.38
Unknown focus 26 (5.4) 0 (0.0) 26 (6.0) 0.10
Initial vital signs
Systolic blood pressure (mmHg) 94 (78–122) 108 (78–134) 92 (78–120) 0.07
Diastolic blood pressure (mmHg) 57 (48–69) 59 (50–74) 57 (47–69) 0.36
Respiratory rate (per minute) 21 (20–24) 20 (20–25) 21 (20–24) 0.61
Heart rate (per minute) 110 (95–128) 112 (94–133) 110 (95–128) 0.74
Body temperature (°C) 37.5 (36.5–38.6) 38.0 (36.5–39.3) 37.4 (36.5–38.5) 0.10
Culture positive
Blood 249 (51.4) 179 (51.7) 59 (51.3) 0.95
Other 225 (46.5) 171 (49.4) 48 (41.7) 0.17
Resistance to initial antibiotics 52 (10.7) 7 (14.3) 45 (10.3) 0.46
Data are shown as median with interquartile range or as number (%)
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Discussion
This study demonstrated that excluding patients from
the definition of septic shock based on the lactate levels
after fluid resuscitation (initial lactate level >2 mmol/L,
subsequent lactate level ≤2 mmol/L) may be reasonable,
as low 28-day mortality (8.2%) was observed in these pa-
tients. The patients in whom perfusion was restored also
had low in-hospital mortality and maximum SOFA
scores. However, the other outcome variables (SOFA
score at inclusion, APACHE II score, ICU stay and hos-
pital stay) were not significantly different between the
two groups.
The strength of our study is that it was conducted
using data from a prospective, multi-center registry.
Table 2 Laboratory test findings of the study cohort according to the definition of Sepsis-3
Variables Overall
(N = 484)
Sepsis with restored
perfusion (n = 49)
Sepsis-3 septic shock
(n = 435)
p Measurements
(number)
Initial lactate level (mmol/L) 4.4 (2.8–6.2) 2.7 (2.3–3.8) 4.6 (3.0–6.4) <0.01 484
Subsequent lactate level (mmol/L) 3.5 (2.2–5.5) 1.6 (1.3–1.8) 3.8 (2.5–6.0) < 0.01 451
White blood cell count (∙103/L) 10.3 (5.1–17.8) 11.5 (5.1–18.3) 10.2 (5.1–17.8) 0.46 484
Hemoglobin (g/dL) 11.1 (9.4–13.0) 10.7 (9.3–12.9) 11.2 (9.4–13.0) 0.43 484
Hematocrit (%) 33 (28.9–38.7) 32.2 (28.1–39.1) 33.8 (28.9–38.7) 0.55 484
Platelet count (∙103/L) 133 (63–209) 182 (114–288) 127 (62–201) < 0.01 484
Sodium (mmol/L) 135 (132–139) 135 (132–138) 135 (131–139) 0.50 484
Potassium (mmol/L) 4.1 (3.7–4.6) 4.2 (3.8–4.7) 4.1 (3.6–4.6) 0.22 484
Chloride (mmol/L) 100 (96–104) 100 (95–102) 100 (96–104) 0.33 483
Blood urea nitrogen (mg/dL) 30 (21–45) 28 (18–38) 30 (21–46) 0.07 480
Creatinine (mg/dL) 1.6 (1.1–2.5) 1.4 (0.9–2.3) 1.7 (1.1–2.6) 0.07 480
AST (U/L) 47 (27–119) 36 (24–93) 48 (27–122) 0.15 483
ALT (U/L) 30 (16–73) 24 (13–63) 30 (16–75) 0.14 483
Albumin (g/dL) 2.9 (2.4–3.3) 3.2 (2.7–3.4) 2.9 (2.4–3.3) 0.10 472
Prothrombin time (INR) 1.4 (1.2–1.6) 1.3 (1.1–1.4) 1.4 (1.2–1.6) 0.01 476
C-reactive protein (mg/dL) 13.5 (5.8–21.8) 12.5 (7.0–19.1) 14.0 (5.7–21.9) 0.90 482
Glucose (mg/dL) 135 (102–193) 148 (117–201) 135 (101–192) 0.20 483
Arterial pH 7.42 (7.35–7.47) 7.45 (7.39–7.49) 7.41 (7.34–7.46) < 0.01 480
PaCO2 (mmHg) 28.0 (23.0–33.0) 28.8 (24.6–35.4) 27.8 (23.0–32.5) 0.10 480
PaO2 (mmHg) 77.5 (63.9–96.0) 76.0 (63.3–94.3) 78.0 (64.0–96.0) 0.87 480
Bicarbonate (arterial, mmol/L) 17.9 (14.5–21.2) 20.4 (18.0–24.2) 17.7 (14.3–20.7) < 0.01 480
Procalcitonin (mmol/L) 14.1 (3.0–42.9) 5.3 (0.7–25.2) 14.4 (3.3–45.0) 0.02 401
D-dimer (mcg/mL) 5.0 (2.6–11.6) 3.9 (2.8–9.7) 5.2 (2.6–11.8) 0.54 359
Troponin I or T (ng/mL) 0.06 (0.02–0.27) 0.04 (0.02–0.17) 0.07 (0.02–0.30) 0.21 401
Data are shown as median with interquartile range
AST aspartate transaminase, ALT alanine transaminase, BNP brain natriuretic peptide, INR international normalized ratio PaCO2 partial arterial pressure of carbon dioxide
Table 3 Comparison of outcomes between patients with restored perfusion and those compatible with the Sepsis-3 definition
Outcomes Sepsis with restored perfusion (n = 49) Sepsis-3 septic shock (n = 435) p
Mortality at 28 days 4 (8.2%) 115 (26.4%) 0.01
In-hospital mortality 6 (12.2%) 131 (30.1%) 0.03
SOFA score 6.0 (4.0–8.0) 7.0 (5.0–9.0) 0.09
Maximum SOFA score 9.0 (6.0–10.0) 9.0 (7.0–12.0) 0.03
APACHE II 21.0 (15.0–26.0) 21.0 (16.0–27.0) 0.92
ICU stay (days) 4.0 (3.0–5.3) 5.0 (3.0–9.0) 0.26
Hospital stay (days) 12.0 (7.0–16.0) 14.0 (7.0–26.0) 0.26
Data are shown as median with interquartile range or as number (%)
SOFA Sequential Organ Failure Assessment, APACHE Acute Physiology and Chronic Health Evaluation, ICU intensive care unit.
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Data in this registry are centrally reviewed and regularly
controlled by research coordinators, for quality control.
Furthermore, the original inclusion criteria of the regis-
try were based on the Surviving Sepsis Campaign 2012;
therefore, a few patients who were compatible with the
Sepsis-3 definition may have been excluded [10]. In
addition, in this study, all the subsequent lactate levels
were obtained after volume resuscitation, as per the
protocol, within 6 hours after ED arrival. To the best of
our knowledge, this is the first study to examine the
prognosis of patients who were excluded from the defin-
ition of septic shock, based on their lactate levels after
initial fluid resuscitation.
The International Guidelines for Management of Se-
vere Sepsis and Septic Shock recommended the use of
bundles for the treatment of sepsis [10]. It was recom-
mended that lactate levels be measured within 3 hours
after admission to the ED, and re-measured within 6
hours [10, 13]. Current guidelines also recommend tar-
geting resuscitation to normalize lactate levels, and sug-
gest that lactate levels are a useful predictor of various
diseases [14–17]. Based on this, lactate measurement for
the early recognition of hypoperfusion and cryptogenic
shock has been widely used [8, 10]. Levy et al. reported
that the mortality was high in patients with both
hypotension requiring the use of vasopressors and lac-
tate levels ≥4 mmol/L (46.1%), while 36.7% mortality
was observed in patients with hypotension alone [18].
However, the lactate levels in the previous study were
different from those in our study, and it is not clear if
they were measured initially or after volume resuscita-
tion. In our study, 28-day mortality in the patients with
restored perfusion was significantly lower compared to
patients with Sepsis-3 septic shock. It is suggested that
the patients in the Sepsis-3 septic shock group had
higher mortality due to hypoperfusion and inadequate
resuscitation. Initial higher systolic blood pressure and
lower lactate in patients in the restored perfusion group
might explain our results. It is also possible that mortal-
ity in the excluded group was lower, reflecting the small
number of seriously ill patients, based on the signifi-
cantly lower maximum SOFA score. According to
Sepsis-3, the clinical diagnostic criteria for septic shock
are based on lactate levels after volume resuscitation,
whereas treatment guidelines recommend the use of ini-
tial lactate levels for the identification of cryptic shock.
However, no studies to date have investigated the impact
of excluding patients in whom perfusion is restored
following sepsis. In the Sepsis-3 septic shock group, in-
hospital mortality was significantly higher in patients
with fluid-resistant hypotension requiring vasopressors
and hyperlactatemia (≥2 mmol/L) compared to those
who had hypotension alone (42.3% vs 30.1%) [19]. How-
ever, this comparison was conducted using the lactate
levels after volume resuscitation, and not the initial
values. Therefore, our study advocates the exclusion of
patients, in whom perfusion was restored following
sepsis, from the Sepsis-3 definition.
This study had several limitations. The main limitation
involves the observation that e mortality rates in the ex-
cluded patients were lower than those in the patients
with initially normal lactate levels, raising concerns
about the extent of bias in the results. Although difficult
to explain, it may be attributed to the small number of
patients in whom perfusion was restored. Second, the
187 patients who were lost to follow up for measure-
ment of lactate levels may also preclude strong conclu-
sions. Third, several patients were excluded due to the
lack of informed consent. In addition, we focused on pa-
tients with early septic shock in the ED, and not in the
ICU, which might have led to selection bias. Even
though our study used data from a prospective, multi-
center registry, some laboratory variables were not ob-
tained in all patients. However, these laboratory variables
were not of interest to us, and did not affect our main
results. In addition, because this was a multi-center
study, the enrollment periods and case volumes varied
by hospital, and institutional characteristics were not ad-
justed for the analysis. Although our patients underwent
protocol-driven septic shock management, it could have
affected our results.
Conclusions
The 28-day mortality in patients who were excluded
from the definition of septic shock based on lactate
levels after fluid resuscitation was very low (8.2%), which
Table 4 The 28-day mortality in the study cohort according to lactate level, hypotension, and vasopressor requirement
Cohorts Mortality at 28 days, number/total number
of patients per group (percentage)
Group 1 (hypotensive after fluids and vasopressor therapy and serum lactate levels >2 mmol/L) 111/435 (25.5%)
Group 2 (hypotensive after fluids and vasopressor therapy and serum lactate levels ≤2 mmol/L) 18/132 (13.6%)
Group 3 (hypotensive after fluids and no vasopressors and serum lactate levels >2 mmol/L) 18/77 (23.4%)
Group 4 (serum lactate levels >2 mmol/L and no hypotension after fluids and no vasopressors) 20/82 (24.4%)
Group 5 (serum lactate levels between 2-4 mmol/L and no hypotension before fluids and no vasopressors) Not applicable
Group 6 (hypotensive after fluids and no vasopressors and serum lactate ≤2 mmol/L) 8/86 (9.3%)
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suggests that this exclusion seems appropriate. Our re-
sult might help clinicians make a consistent diagnosis of
septic shock and to unify communication in both the
clinical and research settings. However, owing to the
small number of patients in whom lactate levels were
improved, further study is warranted.
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